62 results
8-K
EX-99.1
LBPH
Longboard Pharmaceuticals Inc
10 Jun 24
Regulation FD Disclosure
9:05am
a median seizure reduction of 57.3%
Favorable safety and tolerability results observed
100% of participants who completed the PACIFIC Study entered … with Developmental and Epileptic Encephalopathies.
“We are thrilled to see a sustained, durable response in seizure reduction and a favorable safety
8-K
LBPH
Longboard Pharmaceuticals Inc
10 Jun 24
Regulation FD Disclosure
9:05am
and Epileptic Encephalopathies ("DEEs").
The PACIFIC OLE Study is a 52-week Phase 2, open-label, long-term safety study of bexicaserin in participants … ). The study objectives are to investigate the safety and tolerability of multiple doses of bexicaserin in participants with DEEs, and to analyze
8-K
EX-99.2
LBPH
Longboard Pharmaceuticals Inc
10 Jun 24
Regulation FD Disclosure
9:05am
) Sustained response over an approximate 6-month treatment period Favorable safety and tolerability results observed PACIFIC (201 Study) Placebo … ) baseline in monthly seizure frequency Transition to OLE dose
AE=adverse event; n=number of participants; SAE=serious AE; TEAE, treatment-emergent AE Safety
8-K
g1otv bmvk
15 Apr 24
Regulation FD Disclosure
9:16am
PRE 14A
9nxv7bvddkslj5u4
28 Mar 24
Preliminary proxy
4:36pm
S-3ASR
js7i98fijil
12 Mar 24
Automatic shelf registration
4:45pm
8-K
EX-99.1
q0lfrcld f33k106
12 Mar 24
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
4:10pm
8-K
EX-99.2
gtlgszh
12 Mar 24
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
4:10pm
8-K
EX-1.1
h29lx8mh9bsd
4 Jan 24
Other Events
4:51pm
424B5
cb3jkg 39
4 Jan 24
Prospectus supplement for primary offering
4:48pm
424B5
aae29pmyku3zgkv
2 Jan 24
Prospectus supplement for primary offering
4:54pm
8-K
EX-99.1
m640sm pe1mr3d
2 Jan 24
Regulation FD Disclosure
9:44am
8-K
6624ll 5b15s
2 Jan 24
Regulation FD Disclosure
9:44am
8-K
EX-99.2
3t2o12 dr30
2 Jan 24
Regulation FD Disclosure
9:44am
8-K
EX-99.1
tk6i38
29 Nov 23
Regulation FD Disclosure
8:35am